Diagnostic value of serum proteomic assay for pulmonary tuberculosis: evidence from a Meta-analysis_West China Medical Journal

Authors：

LI Dajiang ^1,2 , QIN Jiangyue ³ , LIU Kun ³ , SHEN Yongchun ³ ,  CHEN Xuerong ³ , TANG Xiaoyan ³

1. Department of Medical Affairs, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
2. Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
3. Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

CHEN Xuerong, Email: 384481688@qq.com

Keywords：

Proteomic assay; Pulmonary tuberculosis; Diagnosis; Meta-analysis

DOI：

10.7507/1002-0179.201807133

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

ObjectiveTo summarize the overall diagnostic accuracy of serum proteomic assay for pulmonary tuberculosis through a Meta-analysis.MethodsStudies regarding the diagnostic utility of serum proteomic assay for pulmonary tuberculosis were searched in Scopus, PubMed, Wanfang, China National Knowledge Infrastructure, and CQVIP. The methodical quality was evaluated by Quality Assessment for Studies of Diagnostic Accuracy Studies-2 tool. The pooled sensitivity, specificity, positive/negative likelihood ratios, and diagnostic odds ratio were calculated. Summary receiver operating characteristic curve was generated and the area under the curve was calculated.ResultsThere were 10 articles with 2 433 patients included in this study, containing 1 191 cases and 1 242 controls. The pooled sensitivity, specificity, positive/negative likehood ratios, and diagnostic odds ratio were 0.86, 0.88, 6.72, 0.17, and 46.84, respectively. The area under the curve was 0.93.ConclusionSerum proteomic assay plays a role in diagnosing pulmonary tuberculosis, and proteomic assay represents a novel and useful method for diagnosing pulmonary tuberculosis.

Citation： LI Dajiang, QIN Jiangyue, LIU Kun, SHEN Yongchun, CHEN Xuerong, TANG Xiaoyan. Diagnostic value of serum proteomic assay for pulmonary tuberculosis: evidence from a Meta-analysis. West China Medical Journal, 2018, 33(8): 977-983. doi: 10.7507/1002-0179.201807133 Copy

1.	世界卫生组织. 2017全球结核病报告. (2018-01-28)[2018-06-01]. http://www.who.int/tb/publications/global_report/gtbr2017_executive_summary_zh.pdf?ua=1.
2.	陈大川, 王在义. 肺结核诊断的研究进展. 临床肺科杂志, 2016, 21(1): 145-148.
3.	Lawn SD. Diagnosis of pulmonary tuberculosis. Curr Opin Pulm Med, 2013, 19(3): 280-288.
4.	孙会姗, 潘丽萍, 贾红彦, 等. 血清蛋白质组学技术在结核病诊断中的研究进展. 中华结核和呼吸杂志, 2017, 40(5): 363-365.
5.	Agranoff D, Fernandez-Reyes D, Papadopoulos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet, 2006, 368(9540): 1012-1021.
6.	Liu Q, Pan L, Han F, et al. Proteomic profiling for plasma biomarkers of tuberculosis progression. Mol Med Rep, 2018, 18(2): 1551-1559.
7.	刘琦, 刘新宇, 张仁卿, 等. 汉、藏族肺结核患者血清差异蛋白质的质谱分析. 第三军医大学学报, 2010, 32(18): 1986-1990.
8.	Liu J, Jiang T, Jiang F, et al. Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. Int J Clin Exp Med, 2015, 8(2): 2077-2085.
9.	Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
10.	温红侠, 陈一强, 何敏, 等. 采用蛋白芯片筛选活动性肺结核血清标志物. 中华结核和呼吸杂志, 2008, 31(1): 63-64.
11.	吴雪琼, 张俊仙, 梁艳, 等. 应用蛋白质谱建立活动性肺结核病的血清诊断模型. 中华微生物学和免疫学杂志, 2008, 28(11): 1040-1043.
12.	Liu Q, Chen X, Hu C, et al. Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry. Lung, 2010, 188(1): 15-23.
13.	翁丽珍, 王琳, 李学玲, 等. 肺结核蛋白指纹图谱诊断技术研究. 中国人兽共患病学报, 2010, 26(11): 1048-1051.
14.	Deng C, Lin M, Hu C, et al. Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis. Scand J Immunol, 2011, 74(4): 397-405.
15.	Liu JY, Jin L, Zhao MY, et al. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Clin Chem Lab Med, 2011, 49(10): 1727-1733.
16.	王琳, 翁丽珍, 李学玲, 等. 蛋白质指纹图谱技术在肺结核、肺癌鉴别诊断中的应用研究. 中国防痨杂志, 2011, 33(4): 209-213.
17.	Zhang J, Wu X, Shi L, et al. Diagnostic serum proteomic analysis in patients with active tuberculosis. Clin Chim Acta, 2012, 413(9/10): 883-887.
18.	Liu J, Jiang T, Wei L, et al. The discovery and identification of a candidate proteomic biomarker of active tuberculosis. BMC Infect Dis, 2013, 13(1): 506.
19.	De Groote MA, Sterling DG, Hraha T, et al. Discovery and validation of a six-marker serum protein signature for the diagnosis of active pulmonary tuberculosis. J Clin Microbiol, 2017, 55(10): 3057-3071.
20.	Zhang X, Liu F, Li Q, et al. A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection. Diagn Microbiol Infect Dis, 2014, 79(4): 432-437.
21.	Zhang L, Wang Q, Wang W, et al. Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis. Proteome Sci, 2012, 10: 12.
22.	Nahid P, Bliven-Sizemore E, Jarlsberg LG, et al. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis (Edinb), 2014, 94(3): 187-196.
23.	Xu D, Li Y, Li X, et al. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics, 2015, 15(1): 58-67.

1. 世界卫生组织. 2017全球结核病报告. (2018-01-28)[2018-06-01]. http://www.who.int/tb/publications/global_report/gtbr2017_executive_summary_zh.pdf?ua=1.
2. 陈大川, 王在义. 肺结核诊断的研究进展. 临床肺科杂志, 2016, 21(1): 145-148.
3. Lawn SD. Diagnosis of pulmonary tuberculosis. Curr Opin Pulm Med, 2013, 19(3): 280-288.
4. 孙会姗, 潘丽萍, 贾红彦, 等. 血清蛋白质组学技术在结核病诊断中的研究进展. 中华结核和呼吸杂志, 2017, 40(5): 363-365.
5. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet, 2006, 368(9540): 1012-1021.
6. Liu Q, Pan L, Han F, et al. Proteomic profiling for plasma biomarkers of tuberculosis progression. Mol Med Rep, 2018, 18(2): 1551-1559.
7. 刘琦, 刘新宇, 张仁卿, 等. 汉、藏族肺结核患者血清差异蛋白质的质谱分析. 第三军医大学学报, 2010, 32(18): 1986-1990.
8. Liu J, Jiang T, Jiang F, et al. Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. Int J Clin Exp Med, 2015, 8(2): 2077-2085.
9. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
10. 温红侠, 陈一强, 何敏, 等. 采用蛋白芯片筛选活动性肺结核血清标志物. 中华结核和呼吸杂志, 2008, 31(1): 63-64.
11. 吴雪琼, 张俊仙, 梁艳, 等. 应用蛋白质谱建立活动性肺结核病的血清诊断模型. 中华微生物学和免疫学杂志, 2008, 28(11): 1040-1043.
12. Liu Q, Chen X, Hu C, et al. Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry. Lung, 2010, 188(1): 15-23.
13. 翁丽珍, 王琳, 李学玲, 等. 肺结核蛋白指纹图谱诊断技术研究. 中国人兽共患病学报, 2010, 26(11): 1048-1051.
14. Deng C, Lin M, Hu C, et al. Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis. Scand J Immunol, 2011, 74(4): 397-405.
15. Liu JY, Jin L, Zhao MY, et al. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Clin Chem Lab Med, 2011, 49(10): 1727-1733.
16. 王琳, 翁丽珍, 李学玲, 等. 蛋白质指纹图谱技术在肺结核、肺癌鉴别诊断中的应用研究. 中国防痨杂志, 2011, 33(4): 209-213.
17. Zhang J, Wu X, Shi L, et al. Diagnostic serum proteomic analysis in patients with active tuberculosis. Clin Chim Acta, 2012, 413(9/10): 883-887.
18. Liu J, Jiang T, Wei L, et al. The discovery and identification of a candidate proteomic biomarker of active tuberculosis. BMC Infect Dis, 2013, 13(1): 506.
19. De Groote MA, Sterling DG, Hraha T, et al. Discovery and validation of a six-marker serum protein signature for the diagnosis of active pulmonary tuberculosis. J Clin Microbiol, 2017, 55(10): 3057-3071.
20. Zhang X, Liu F, Li Q, et al. A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection. Diagn Microbiol Infect Dis, 2014, 79(4): 432-437.
21. Zhang L, Wang Q, Wang W, et al. Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis. Proteome Sci, 2012, 10: 12.
22. Nahid P, Bliven-Sizemore E, Jarlsberg LG, et al. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis (Edinb), 2014, 94(3): 187-196.
23. Xu D, Li Y, Li X, et al. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics, 2015, 15(1): 58-67.

West China Medical Journal

Diagnostic value of serum proteomic assay for pulmonary tuberculosis: evidence from a Meta-analysis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content